Lafutidine
SIGMA/SML1611 - ≥98% (HPLC)
Synonym: (Z)
CAS Number: 118288-08-7
Empirical Formula (Hill Notation): C22H29N3O4S
Molecular Weight: 431.55
MDL Number: MFCD00867520
Linear Formula: C22H29N3O4S
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C22H29N3O4S/c26-21(18- |
InChI key | KMZQAVXSMUKBPD-DJWKRKHSSA |
Quality Level | 100 |
SMILES string | O=C(CS(CC1=CC=CO1)=O)NC/C |
solubility | DMSO: 20 mg/mL, clear |
storage temp. | −20°C |
Biochem/physiol Actions: | Lafutidine is a second generation H2 histamine receptor antagonist. Lafutidine has been used clinically to treat ulcers and gastro-esophageal reflux disease (GERD). Lafutidine has also been investigated as a treatment against peripheral neuropathy and for its protective stomach effects during cancer chemotherapies and long term ibuprofen use. |
Packaging: | 10, 50 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P301 + P312 + P330 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 1 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |